title: Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer.
abstract: OBJECTIVE
  To investigate the expression profile of IL-8 in inflammatory and malignant colorectal diseases to evaluate its potential role in the regulation of colorectal cancer (CRC) and the development of colorectal liver metastases (CRLM).
  
  
  METHODS
  IL-8 expression was assessed by quantitative real-time PCR (Q-RT-PCR) and the enzyme-linked immunosorbent assay (ELISA) in resected specimens from patients with ulcerative colitis (UC, n = 6) colorectal adenomas (CRA, n = 8), different stages of colorectal cancer (n = 48) as well as synchronous and metachronous CRLM along with their corresponding primary colorectal tumors (n = 16).
  
  
  RESULTS
  IL-8 mRNA and protein expression was significantly up-regulated in all pathological colorectal entities investigated compared with the corresponding neighboring tissues. However, in the CRC specimens IL-8 revealed a significantly more pronounced overexpression in relation to the CRA and UC tissues with an average 30-fold IL-8 protein up-regulation in the CRC specimens in comparison to the CRA tissues. Moreover, IL-8 expression revealed a close correlation with tumor grading. Most interestingly, IL-8 up-regulation was most enhanced in synchronous and metachronous CRLM, if compared with the corresponding primary CRC tissues. Herein, an up to 80-fold IL-8 overexpression in individual metachronous metastases compared to normal tumor neighbor tissues was found.
  
  
  CONCLUSIONS
  Our results strongly suggest an association between IL-8 expression, induction and progression of colorectal carcinoma and the development of colorectal liver metastases.
authors.affiliation: Labor fur Allgemein-, Viszeral-, GefaSS- und Kinderchirurgie, Universitatsklinikum des Saarlandes, Chirurgische Klinik, Gebaude 57, Homburg 66421, Germany. ca.labor@uniklinik-saarland.de
authors.forename: Claudia
authors.initials: C
authors.lastname: Rubie
authors.forename: Vilma Oliveira
authors.initials: VO
authors.lastname: Frick
authors.forename: Sandra
authors.initials: S
authors.lastname: Pfeil
authors.forename: Mathias
authors.initials: M
authors.lastname: Wagner
authors.forename: Otto
authors.initials: O
authors.lastname: Kollmar
authors.forename: Berit
authors.initials: B
authors.lastname: Kopp
authors.forename: Stefan
authors.initials: S
authors.lastname: Graber
authors.forename: Bettina M
authors.initials: BM
authors.lastname: Rau
authors.forename: Martin K
authors.initials: MK
authors.lastname: Schilling
mesh_terms: D000236:Adenoma / Q000378:metabolism* / Q000473:pathology; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism; D015179:Colorectal Neoplasms / Q000378:metabolism* / Q000473:pathology; D018450:Disease Progression; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D016209:Interleukin-8 / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging
chemical_list: D014408:Biomarkers, Tumor; D016209:Interleukin-8